Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy.

Patients receiving specific treatment(s) for COPD demonstrated low persistence for all examined therapy regimens, with no clear impact of persistence status on the frequency of exacerbations at 12 months.